Table 1 –
Technology | CTC definition | Application in PC |
---|---|---|
Antibody-based positive selection | ||
CellSearch | EpCAM+, CD45−, CK8+, CK18+, CK19+, DAPI+ | [57] |
Adna Test | EpCAM+, PSA+/PSMA+/EGFR+ | [15] |
CTC-Chip | EpCAM+, specific antigen+ | [89] |
CTC-iChip | >3.8 μm size, EpCAM+ | [90] |
IsoFlux | CD45−, DAPI+, PanCK+, or EpCAM+ | [91] |
MagSweeper | EpCAM+, CD45−, DAPI + | [10,92] |
CellCollector | EpCAM+, CD45−, PanCK+, PSA+, Hoechst+ | [74] |
NanoVelcro | EpCAM+, CD4−, PanCK+, morphological verification | [93] |
Antibody-based negative selection | ||
EasySep | CD45− | [94] |
RosetteSep | CD45−, CD66b−, glycophorin A−, density | [74] |
EPISPOT | CD45−, CD66b−, glycophorin A−, PSA+, FGF2+ | [74] |
CTC-iChip | CD45−, CD16−, CD66b− | [90] |
Selection free | ||
Epic Sciences | PanCK+, CD45−, DAPI+, AR+ | [9] |
AccuCyte | DAPI+, PanCK+, CD45−, CD66b−, CD11b−, CD14−, CD34−, EpCAM+ | [95] |
Physical properties | ||
ApoStream | Dielectrophoretic field flow | [96] |
Celsee Diagnostics | >7.5 μm, deformability | [97] |
ISET | ≥8 μm | [95] |
CTC = circulating tumor cell; EGFR = epidermal growth factor receptor; PC = prostate cancer; PSA = prostate-specific antigen; PSMA = prostate-specific membrane antigen.
Positive (+) and/or negative (−) expression of different capture/detection antigens, or physical properties, is used as a criterion for CTC isolation by different technologies or platforms.